Dual-Targeting OH2 Oncolytic Virus Therapy Overcomes Immune Resistance in TNBC via PD-L1/DDR1 Silencing and GM-CSF Expression
, , and
BIO Web Conf., 237 (2026) 02009
Published online: 10 June 2026
DOI: 10.1051/bioconf/202623702009

